Small Business Funding for Innovations in Alzheimer’s Disease and Aging

Share on Social Media

The National Institute on Aging (NIA) offers early-stage funding opportunities to small businesses and researchers looking to commercialize innovative treatments or technologies to help people enjoy healthier lives as they age. The NIA Small Business Program is accepting applications for Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) funding. Learn more about these open opportunities. The next deadline to apply is January 5, 2022
Current Funding Opportunities

All applicants should consider submitting through the Omnibus Solicitation, which covers a broad range of NIA research topics and investigator-initiated ideas. For small businesses and research organizations working on solutions for Alzheimer’s disease (AD) and AD-related dementias (ADRD), NIA has targeted solicitations for SBIR and STTR that allow for higher budget limits of up to $500,000 for Phase I and $2.5 million for Phase II. These opportunities are part of NIA’s unprecedented research and development budget to develop AD/ADRD interventions and therapeutics. 

The following opportunities are currently open:2021 NIH SBIR Omnibus Solicitation – Clinical Trial Required SBIR (PA-21-260)STTR (PA-21-261)2021 NIH SBIR Omnibus Solicitation – Clinical Trial Not AllowedSBIR (PA-21-259)STTR (PA-21-262)Advancing Research on Alzheimer’s Disease (AD) and Alzheimer’s Disease-Related Dementias (ADRD)SBIR (PAS-19-316)STTR (PAS-19-317)Commercialization Readiness Pilot (CRP) Program: SBIR & STTR PA-20-128 (SB1, Technical Assistance) — Clinical Trial Not AllowedSBIR & STTR PA-20-129 (SB1, Technical Assistance, and Late Stage Development) — Clinical Trial Not AllowedSBIR & STTR PA-20-130 (SB1, Technical Assistance, and Late Stage Development) — Clinical Trial Required For a list of NIA SBIR and STTR funding opportunities, deadlines, and budget limits, visit the NIA Small Business Program funding page. 

Latest News

RI Bio takes pulse of the life sciences industry

RI Bio takes pulse of the life sciences industry

RI Bio, in collaboration with Providence Business News and RI Bio member AMGEN, has created a unique series of articles addressing key topics of concern designed to advance the life sciences. Executive Director Carol Malysz moderated a series of roundtables with Amgen...

RI Bio Teams Up with Venture Café to Celebrate Life Sciences

RI Bio Teams Up with Venture Café to Celebrate Life Sciences

PROVIDENCE, RI–April 26, 2022–RI Bio, Southeastern New England’s life sciences trade group, announced their slate of NEXT WAVE events with Venture Café Providence every Thursday in May that celebrates the life sciences.  “The pandemic put advances in life sciences and...

RI Bio Board Appoints Two New Directors

RI Bio Board Appoints Two New Directors

PROVIDENCE, RI–March 16, 2022–RI Bio, Southeastern New England’s life sciences trade group, announced the appointment of two new members to its board of directors at its March 16 meeting: Neil Sarkar of the Rhode Island Quality Institute (RIQI) and Jaimy Mauricio of...

Biotech Industry News